Leila Liu-Nguyen
Adult Health · New York, NYNPI 1508424011
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,133 of the $1,407 with a category attached, or 80.5%. It is spread thinly across 21 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $369, 4.6 times the $80 reported in 2021.
Across 62 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$274
- Merck$176
- AstraZeneca$118
- Pfizer$104
- AbbVie$102
- Taiho Oncology, Inc.$93
- plus $540 from 15 others
What the payments were for
- Food & beverage$1,13381%
- Education$27419%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 3 | $274 |
| Merck | 10 | $176 |
| AstraZeneca | 7 | $118 |
| Pfizer | 5 | $104 |
| AbbVie | 6 | $102 |
| Taiho Oncology, Inc. | 5 | $93 |
| Bayer | 1 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $51 |
| Novartis | 3 | $51 |
| Cumberland Pharmaceuticals, Inc. | 3 | $49 |
| Genentech USA, Inc. | 2 | $45 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Eisai Inc. | 2 | $28 |
| Amgen | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $20 |
| Apellis Pharmaceuticals, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Servier Pharmaceuticals LLC | 1 | $14 |
| Immunogen, Inc. | 1 | $14 |
How this compares
$1,407 in reported general payments places this provider in the 75th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 31 | $575 |
| Ondansetron Hcl | 21 | $117 |
| Prochlorperazine Maleate | 16 | $80 |
Paid to pharmacies, not to this prescriber.
Other adult health in New York
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
- Hyo Jin KangNew York$19K
- Monica RicheyNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.